Loading clinical trials...
Loading clinical trials...
Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerabililty of RVT-501 Topical Ointment in Pediatric Patients With Mild to Moderate Atopic Dermatitis
Conditions
Interventions
RVT-501 0.5% ointment
Vehicle ointment
Locations
7
United States
Dermavant Investigational Site
Los Angeles, California, United States
Dermavant Investigational Site
Oklahoma City, Oklahoma, United States
Dermavant Investigational Site
Portland, Oregon, United States
Dermavant Investigational Site
Dallas, Texas, United States
Dermavant Investigational Site
San Antonio, Texas, United States
Dermavant Investigational Site
Surrey, British Columbia, Canada
Start Date
January 25, 2018
Primary Completion Date
July 2, 2018
Completion Date
July 2, 2018
Last Updated
July 19, 2018
NCT07262983
NCT06389136
NCT06342713
NCT07223697
NCT07290803
NCT07265479
Lead Sponsor
Dermavant Sciences GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions